Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas
- PMID: 20889565
- PMCID: PMC2966817
- DOI: 10.2353/ajpath.2010.091075
Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas
Abstract
Loss of the PTEN tumor suppressor gene occurs frequently in non-small-cell lung carcinoma (NSCLC), although neither genetic alterations nor epigenetic silencing are significant predictors of PTEN protein levels. Since recent reports implicated neural precursor cell expressed, developmentally down-regulated 4-1 (NEDD4-1) as the E3 ubiquitin ligase that regulates PTEN stability, we investigated the role of NEDD4-1 in the regulation of PTEN expression in cases of NSCLC. Our findings indicate that NEDD4-1 plays a critical role in the development of NSCLC and provides novel insight on the mechanisms that contribute to inactivate PTEN in lung cancer. Immunohistochemical analysis on tissue microarrays containing 103 NSCLC resections revealed NEDD4-1 overexpression in 80% of tumors, which correlated with the loss of PTEN protein (n=98; P<0.001). Accordingly, adoptive NEDD4-1 expression in NSCLC cells decreased PTEN protein stability, whereas knock-down of NEDD4-1 expression decreased PTEN ubiquitylation and increased PTEN protein levels. In 25% of cases, NEDD4-1 overexpression was due to gene amplification at 15q21. In addition, manipulation of NEDD4-1 expression in different lung cell systems demonstrated that suppression of NEDD4-1 expression significantly reduced proliferation of NSCLC cells in vitro and tumor growth in vivo, whereas NEDD4-1 overexpression facilitated anchorage-dependent and independent growth in vitro of nontransformed lung epithelial cells that lack pRB and TP53 (BEAS-2B). NEDD4-1 overexpression also augmented the tumorigenicity of lung cancer cells that have an intact PTEN gene (NCI-H460 cells).
Figures









Similar articles
-
p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN.Cell Death Differ. 2014 Jan;21(1):146-60. doi: 10.1038/cdd.2013.141. Epub 2013 Oct 18. Cell Death Differ. 2014. PMID: 24141722 Free PMC article.
-
PTEN and NEDD4 in Human Breast Carcinoma.Pathol Oncol Res. 2016 Jan;22(1):41-7. doi: 10.1007/s12253-015-9971-2. Epub 2015 Aug 15. Pathol Oncol Res. 2016. PMID: 26276352 Free PMC article.
-
Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non-small-cell lung cancer.Tumour Biol. 2017 Jul;39(7):1010428317709639. doi: 10.1177/1010428317709639. Tumour Biol. 2017. PMID: 28714370
-
Nedd4 and Nedd4-2: closely related ubiquitin-protein ligases with distinct physiological functions.Cell Death Differ. 2010 Jan;17(1):68-77. doi: 10.1038/cdd.2009.84. Cell Death Differ. 2010. PMID: 19557014 Free PMC article. Review.
-
NEDD4: The founding member of a family of ubiquitin-protein ligases.Gene. 2015 Feb 25;557(2):113-22. doi: 10.1016/j.gene.2014.12.020. Epub 2014 Dec 17. Gene. 2015. PMID: 25527121 Free PMC article. Review.
Cited by
-
NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.Gynecol Oncol. 2015 Oct;139(1):127-33. doi: 10.1016/j.ygyno.2015.07.098. Epub 2015 Jul 17. Gynecol Oncol. 2015. PMID: 26193427 Free PMC article.
-
Nongenomic Mechanisms of PTEN Regulation.Int J Cell Biol. 2012;2012:379685. doi: 10.1155/2012/379685. Epub 2012 Mar 25. Int J Cell Biol. 2012. PMID: 22536248 Free PMC article.
-
The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.Genes (Basel). 2022 Mar 14;13(3):513. doi: 10.3390/genes13030513. Genes (Basel). 2022. PMID: 35328067 Free PMC article. Review.
-
USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression.Mol Oncol. 2022 Mar;16(5):1200-1217. doi: 10.1002/1878-0261.13137. Epub 2021 Nov 16. Mol Oncol. 2022. PMID: 34743406 Free PMC article.
-
Posttranslational regulation of phosphatase and tensin homolog (PTEN) and its functional impact on cancer behaviors.Drug Des Devel Ther. 2014 Oct 6;8:1745-51. doi: 10.2147/DDDT.S71061. eCollection 2014. Drug Des Devel Ther. 2014. PMID: 25336918 Free PMC article. Review.
References
-
- Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 2007;111:1710–1717. - PubMed
-
- Gabrielson E. Worldwide trends in lung cancer pathology. Respirology. 2006;11:533–538. - PubMed
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics. CA Cancer J Clin. 2007;57:43–66. - PubMed
-
- Minna JD, Roth JA, Gazdar AF. Focus on lung cancer. Cancer Cell. 2002;1:49–52. - PubMed
-
- Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005;24:7455–7464. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous